Clinical Trial Update: Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sarcosine as a monotherapy for schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Drugs mentioned

• Sarcosine (sarcosine)

Snippet

Sponsor: China Medical University Hospital | Conditions: Schizophrenias, Psychoses | Phase 2 | Status: COMPLETED